A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -60.25% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -65.73%. Over the past 30 days, the price of PCSA has fallen by 46.99%. And in the last five days, it has surged by 21.85%.
Processa Pharmaceuticals Inc ‘s stock market performance has been somewhat erratic.
52-week price history of PCSA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Processa Pharmaceuticals Inc’s current trading price is -88.67% away from its 52-week high, while its distance from the 52-week low is 134.20%. The stock’s price range during this period has varied between$0.15 and $3.10. The Processa Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.81 million for the day, a figure considerably lower than their average daily volume of 4.02 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Processa Pharmaceuticals Inc (PCSA) has experienced a quarterly decline of -23.26% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.18M and boasts a workforce of 10 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
PCSA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PCSA stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.